EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Genetic biomarker screening for drug-resistant epilepsy in low- and middle-income countries (LMICs)

Dina Kalinina, Alimzhan Muxunov, Zhassulan Utebekov, Gaziz Kyrgyzbay, Darkhan Kimadiev, Guldana Zhumabaeva, Joseph Almazan, Antonio Sarria-Santamera

Advances in Clinical and Experimental Medicine · 20.05.2026 · 35 (5) · 919-928

DOI: 10.17219/acem/209664 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Clinical and Experimental Medicine, online erschienen am 20.05.2026. Verfasst von Dina Kalinina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Nazarbayev University School of Medicine, Astana, Kazakhstan. Hauptthemen laut MEDLINE: Developing Countries, Drug Resistant Epilepsy, Genetic Testing. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Developing CountriesDrug Resistant EpilepsyGenetic TestingHumansGenetic MarkersResource-Limited Settings

Stichwörter der Autor:innen

drug-resistant epilepsygenetic testinglowand middle-income countriespatient selectionsurgical outcomes

Substanzen

Genetic Markers

Autor:innen und Institutionen

  • Department of Medicine, Nazarbayev University School of Medicine, Astana, Kazakhstan.
  • Epileptology Centre, Republican State Enterprise (RSE) Medical Centre Hospital of the President's Affairs Administration of the Republic of Kazakhstan, Astana, Kazakhstan.

Zitieren

APA

Kalinina, D., Muxunov, A., Utebekov, Z., Kyrgyzbay, G., Kimadiev, D., Zhumabaeva, G., Almazan, J., & Sarria-Santamera, A. (2026). Genetic biomarker screening for drug-resistant epilepsy in low- and middle-income countries (LMICs). Advances in Clinical and Experimental Medicine, 35(5), 919-928. https://doi.org/10.17219/acem/209664

Vancouver

Kalinina D, Muxunov A, Utebekov Z, Kyrgyzbay G, Kimadiev D, Zhumabaeva G, et al. Genetic biomarker screening for drug-resistant epilepsy in low- and middle-income countries (LMICs). Advances in Clinical and Experimental Medicine. 2026;35(5):919-928. doi:10.17219/acem/209664

BibTeX
@article{Kalinina2026,
  author = {Kalinina, Dina and Muxunov, Alimzhan and Utebekov, Zhassulan and Kyrgyzbay, Gaziz and Kimadiev, Darkhan and Zhumabaeva, Guldana and Almazan, Joseph and Sarria-Santamera, Antonio},
  title = {Genetic biomarker screening for drug-resistant epilepsy in low- and middle-income countries (LMICs)},
  journal = {Advances in Clinical and Experimental Medicine},
  year = {2026},
  volume = {35},
  number = {5},
  pages = {919--928},
  doi = {10.17219/acem/209664}
}
Kostenlos starten →